Tuberculosis and Respiratory Diseases

  • 제72권6호
  • /
  • Pages.467-474
  • /
  • 2012
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung

  • Lee, Bo-Young (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Seo-Hyun (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Jae-Seung (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Jin-Woo (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Sang-Do (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jang, Seung-Hun (Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Jung, Ki-Suck (Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Hwang, Yong-Il (Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Oh, Yeon-Mok (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2012.02.09
  • 심사 : 2012.04.24
  • 발행 : 2012.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The objective of this study was to assess the validity and reliability of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and Dyspnea-12 Questionnaire for patients with bronchiectasis or tuberculous destroyed lung. Methods: For 62 bronchiectasis patients and 37 tuberculous destroyed lung patients, 3 questionnaires including St. George's Respiratory Questionnaires (SGRQ), CAT, and Dyspnea-12 were obtained, in addition to spirometric measurements. To assess the validity of CAT and Dyspnea-12, correlation with SGRQ was evaluated. To assess the reliability of CAT and Dyspnea-12, Cronbach's ${\alpha}$ coefficient was calculated. Results: The mean ages of the patients were $60.7{\pm}8.3$ years in bronchiectasis and $64.4{\pm}9.3$ years in tuberculous destroyed lung. 46.8% and 54.1% were male, respectively. The SGRQ score was correlated with the score of the Korean version of CAT (r=0.72, p<0.0001) and Dyspnea-12 (r=0.67, p<0.0001) in bronchiectasis patients. The SGRQ score was correlated with the score of CAT (r=0.86, p<0.0001) and Dyspnea-12 (r=0.80, p<0.0001) in tuberculous destroyed lung patients. The Cronbach's ${\alpha}$ coefficient for the CAT and Dyspnea-12 were 0.84 and 0.90 in bronchiectasis, and 0.88 and 0.94 in tuberculous destroyed lung, respectively. Conclusion: We found that Korean version of CAT and Dyspnea-12 are valid and reliable in patients with tuberculous destroyed lung and bronchiectasis.

키워드

참고문헌

  1. Guyatt GH, Feeny DH, Patrick DL. Measuring healthrelated quality of life. Ann Intern Med 1993;118:622-9. https://doi.org/10.7326/0003-4819-118-8-199304150-00009
  2. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997;156(4 Pt 1):1032-9. https://doi.org/10.1164/ajrccm.156.4.97-02011
  3. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155:1283-9. https://doi.org/10.1164/ajrccm.155.4.9105068
  4. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991;85 Suppl B:25-31. https://doi.org/10.1016/S0954-6111(06)80166-6
  5. Kim YS, Byun MK, Jung WY, Jeong JH, Choi SB, Kang SM, et al. Validation of the Korean version of the St. George's respiratory questionnaire for patients with chronic respiratory disease. Tuberc Respir Dis 2006;61: 121-8. https://doi.org/10.4046/trd.2006.61.2.121
  6. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer G, et al. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 2007;132: 1591-8. https://doi.org/10.1378/chest.07-0755
  7. Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997;156(2 Pt 1):536-41. https://doi.org/10.1164/ajrccm.156.2.9607083
  8. Lee BH, Kim YS, Lee KD, Lee JH, Kim SH. Health-related quality of life measurement with St. George's respiratory questionnaire in post-tuberculous destroyed lung. Tuberc Respir Dis 2008;65:183-90. https://doi.org/10.4046/trd.2008.65.3.183
  9. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34:648-54. https://doi.org/10.1183/09031936.00102509
  10. Lee S, Lee JS, Song JW, Choi CM, Shim TS, Kim TB, et al. Validation of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and Dyspnea-12 questionnaire. Tuberc Respir Dis 2010;69: 171-6. https://doi.org/10.4046/trd.2010.69.3.171
  11. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis 1986;134:1129-34.
  12. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax 2010;65:21-6. https://doi.org/10.1136/thx.2009.118521
  13. Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med 2003;97:1237-42. https://doi.org/10.1016/S0954-6111(03)00255-5
  14. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in korean population. Tuberc Respir Dis 2005;58:230-42. https://doi.org/10.4046/trd.2005.58.3.230
  15. World Health Organization. Global tuberculosis control: WHO report 2011. Geneva: World Health Organization; 2011.
  16. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007;131:1817-24. https://doi.org/10.1378/chest.06-2949
  17. Barker AF. Bronchiectasis. N Engl J Med 2002;346:1383-93. https://doi.org/10.1056/NEJMra012519

피인용 문헌

  1. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis vol.13, pp.None, 2012, https://doi.org/10.1186/1471-2466-13-21
  2. Perceived breathlessness and psychological distress among patients with chronic obstructive pulmonary disease and their spouses vol.16, pp.1, 2012, https://doi.org/10.1111/nhs.12073
  3. Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study vol.16, pp.None, 2015, https://doi.org/10.1186/s12931-015-0167-9
  4. Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation vol.17, pp.None, 2012, https://doi.org/10.1186/s12931-016-0380-1
  5. The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis vol.71, pp.8, 2012, https://doi.org/10.1136/thoraxjnl-2015-207315
  6. Dyspnoea-12: a translation and linguistic validation study in a Swedish setting vol.7, pp.5, 2012, https://doi.org/10.1136/bmjopen-2016-014490
  7. Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding vol.49, pp.3, 2012, https://doi.org/10.1183/13993003.02473-2016
  8. Investigation into the Individualized Treatment of Traditional Chinese Medicine through a Series of N-of-1 Trials vol.2018, pp.None, 2012, https://doi.org/10.1155/2018/5813767
  9. COPD Assessment Test (CAT) is a Valid and Simple Tool to Measure the Impact of Bronchiectasis on Affected Patients vol.15, pp.5, 2012, https://doi.org/10.1080/15412555.2018.1540034
  10. Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease vol.6, pp.1, 2012, https://doi.org/10.1136/bmjresp-2019-000418
  11. Effectiveness of non-pharmacological COPD management on health-related quality of life - a systematic review vol.20, pp.1, 2012, https://doi.org/10.1080/14737167.2020.1734455
  12. COPD Assessment Test in Bronchiectasis: Minimum Clinically Important Difference and Psychometric Validation vol.157, pp.4, 2012, https://doi.org/10.1016/j.chest.2019.08.1916
  13. A Series of N-of-1 Trials for Traditional Chinese Medicine Using a Bayesian Method: Study Rationale and Protocol vol.2021, pp.None, 2012, https://doi.org/10.1155/2021/9976770
  14. Adaptation and validation of the Chinese version of Dyspnoea‐12 scale in individuals with chronic obstructive pulmonary disease vol.15, pp.10, 2021, https://doi.org/10.1111/crj.13411
  15. Adaptation and validation of the Chinese version of Dyspnoea‐12 scale in individuals with chronic obstructive pulmonary disease vol.15, pp.10, 2021, https://doi.org/10.1111/crj.13411